PharmaCyte Biotech (PMCB) Cash from Financing Activities (2010 - 2026)
PharmaCyte Biotech's Cash from Financing Activities was -$83,399 in fiscal Q1 2027 (quarter ended Jul 31, 2026).
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Cash from Financing Activities (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, PharmaCyte Biotech's Cash from Financing Activities was $6.5 million through Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it was $6.58 million.
- Cash from Financing Activities shows a five-year compound annual growth rate of 7.3% (FY2021 to FY2026).
- In earlier fiscal years, Cash from Financing Activities was -$25.03 million in FY2025, -$10.71 million in FY2024, -$13.56 million in FY2023 and $87.31 million in FY2022.
- Quarterly Cash from Financing Activities has moved between -$10.74 million (fiscal Q2 2025) and $87.36 million (fiscal Q2 2022) over five years.
- Per Business Quant data, PMCB's Cash from Financing Activities in the three fiscal quarters before Q1 2027 was -$169,818 (Q4 2026), $543,779 (Q3 2026) and $6.21 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | -83,399.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -83,399.00 |
| Apr 30, 2026 | -169,818.00 |
| Jan 31, 2026 | 543,779.00 |
| Oct 31, 2025 | 6.21 Mn |
| Apr 30, 2025 | -171,543.00 |
| Jan 31, 2025 | -3.95 Mn |
| Oct 31, 2024 | -10.74 Mn |
| Jul 31, 2024 | -10.17 Mn |
| Apr 30, 2024 | -10.70 Mn |
| Jan 31, 2024 | -7.04 Mn |
| Oct 31, 2023 | 748,687.00 |
| Jul 31, 2023 | 6.28 Mn |
| Apr 30, 2023 | -4.31 Mn |
| Jan 31, 2023 | -3.78 Mn |
| Oct 31, 2022 | -3.39 Mn |
| Jul 31, 2022 | -2.09 Mn |
| Apr 30, 2022 | -50,805.00 |
| Oct 31, 2021 | 87.36 Mn |
| Apr 30, 2021 | 50,805.00 |
| Jan 31, 2021 | -38,169.00 |
API Access
PharmaCyte Biotech Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();